AAV
Biosafety Testing
Gene Therapy
Testing
Minaris Advanced Testing delivers comprehensive, GMP-compliant AAV lot release testing to support gene therapy programs from early development through commercialization. Backed by more than 40 years of biosafety expertise, our advanced molecular biology and analytical platforms which include PCR/ddPCR, next-generation sequencing, and orthogonal methods, ensure robust evaluation of identity, purity, potency, and safety. With a strong focus on rapid microbiological methods and regulatory-ready testing strategies, we help you achieve confident, efficient product release.
Download the flyer to explore our full AAV lot release testing panel and see how Minaris can support your program with reliable, high-quality results.
